Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Brain tumour - suspected - Management
View full scenario

General recommendations

  • A patient who presents with symptoms suggestive of brain or CNS cancer should be referred to an appropriate specialist, depending on local arrangements (D).
  • If a primary healthcare professional has concerns about the interpretation of a patient's symptoms and/or signs, a discussion with a local specialist should be considered. If rapid access to scanning is available, this investigation should also be considered as an alternative (D).
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

Headaches

  • In patients with headaches of recent onset accompanied by either features suggestive of raised intracranial pressure (for example, vomiting, drowsiness, posture-related headache, headache with pulse-synchronous tinnitus) or other focal or non-focal neurological symptoms (for example, blackout, change in personality or memory), an urgent referral should be made (C).
  • In patients with unexplained headaches of recent onset, present for at least 1 month but not accompanied by features suggestive of raised intracranial pressure, discussion with a local specialist or referral (usually non-urgent) should be considered (D).
  • In patients with a new, qualitatively different unexplained headache that becomes progressively severe, an urgent referral should be made (C).
  • Re-assessment and re-examination is required if the patient does not progress according to expectations (D).
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

Seizures

  • A detailed history should be taken from the patient and an eyewitness to the event if possible, to determine whether or not a seizure is likely to have occurred (C).
  • In patients presenting with a seizure, a physical examination (including cardiac, neurological, mental state) and developmental assessment, where appropriate, should be carried out (C).
  • In any patient with suspected recent-onset seizures, an urgent referral to a neurologist should be made (C).
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

The recommendation to take a detailed seizure history is based on the National Institute for Health and Clinical Excellence guideline The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care [NICE, 2004].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

Other neurological features

  • An urgent referral to an appropriate specialist should be considered for patients with rapid progression of:
    • Subacute focal neurological deficit (B).
    • Unexplained cognitive impairment, behavioural disturbance, or slowness or a combination of these (C).
    • Personality changes confirmed by a witness (for example, a carer, friend or a family member) and for which there is no reasonable explanation even in the absence of the other symptoms and signs of a brain tumour (D).
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

Risk factors

  • In patients previously diagnosed with any cancer an urgent referral should be made if the patient develops any of the following symptoms: (C)
    • Recent-onset seizure
    • Progressive neurological deficit
    • Persistent headaches
    • New mental or cognitive changes
    • New neurological signs
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

Referral timelines

The referral timelines used in this guideline are as follows:

  • Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.
  • Urgent: the patient is seen within the national target for urgent referrals (currently 2 weeks).
  • Non-urgent: all other referrals.
Basis for recommendation

This is a direct implementation of the National Institute for Health and Clinical Excellence guideline Referral guidelines for suspected cancer: brain and CNS cancer [NICE, 2005].

For further information on the evidence grading used, see the Supporting evidence section on Evidence grading.

© NHS Institute for Innovation and Improvement